Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference

Data presentations including the extended LIBERTY studies to highlight the long-term treatment goals of

™ is a self-injected form of infliximab and thus will be under patent protection for its dosage form by 2037 and for its route of administration by 2040. ?SERIOUS INFECTIONSPatients treated with . Invasive fungal infections, including histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, and pneumocystosis. Patients may present with disseminated, rather than localized, disease. Empiric anti-fungal therapy should be considered in patients at risk for invasive fungal infections who develop severe systemic illness. Bacterial, viral, and other infections due to opportunistic pathogens, including Legionella and Listeria.

is contraindicated in patients with a previous severe hypersensitivity reaction to infliximab-dyyb, other infliximab products, any of the inactive ingredients of . Discontinue has not been studied in patients with a history of CHF and . If a clinically significant injection-site reaction occurs, institute appropriate therapy and discontinue

with other immunosuppressive biological products used to treat UC and CD may increase the risk of infection and is not recommended.RISK OF ADDITIVE IMMUNOSUPPRESSIVE EFFECTS FROM PRIOR BIOLOGICAL PRODUCTSConsider the half-life and mode of action of prior biological products to avoid unintended additive immunosuppressive effects when initiating

Source: Healthcare Press (healthcarepress.net)

USA Announces Two-Year Data For ZYMFENTRA™(Infliximab-Dyyb) To Be Presented At Digestive Disease Week (DDW) 2024 Conference

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Miss USA and Miss Teen USA resign from their positionsMiss USA 2023 Noelia Voigt and Miss Teen USA 2023 UmaSofia Srivastava have both resigned from their positions.
Source: gmanews - 🏆 11. / 68 Read more »

Filipino-American Savannah Gankiewicz assumes Miss USA 2023 crown amid resignation controversyFilipino American Miss Hawaii 2023, Savannah Gankiewicz, 28, assumes the title of Miss USA 2023 following the resignation of Noelia Voigt of Utah, who stepped down as Miss USA 2023 on May 6.
Source: gmanews - 🏆 11. / 68 Read more »

Mutya ng Pilipinas finalist crowned Miss USA 2023Former Mutya ng Pilipinas candidate Savannah Gankiewicz has been crowned as the new Miss USA 2023 after Noelia Voigt relinquished her title.
Source: PhilstarNews - 🏆 1. / 94 Read more »

Ex-Mutya ng Pilipinas candidate to represent USA at Miss Universe 2024Former Mutya ng Pilipinas candidate Savannah Gankiewicz has been crowned as the new Miss USA 2023 after Noelia Voigt relinquished her title.
Source: PhilstarNews - 🏆 1. / 94 Read more »

Mutya ng Pilipinas finalist to represent USA at Miss Universe 2024Former Mutya ng Pilipinas candidate Savannah Gankiewicz has been crowned as the new Miss USA 2023 after Noelia Voigt relinquished her title.
Source: PhilstarNews - 🏆 1. / 94 Read more »

Miss Teen USA 2023 1st runner-up declines title after winner’s resignationMiss Teen USA 2023 first runner-up Stephanie Skinner has declined the crown after reigning title holder UmaSofia Srivastava resigned from her post.
Source: gmanews - 🏆 11. / 68 Read more »